Amarin Appeals FDA Ruling On Fish Oil Drug's Expansion
Amarin Corp. PLC on Thursday appealed a U.S. Food and Drug Administration panel's denial of expanded use of its fish oil drug Vascepa among adults with high cholesterol levels, saying in...To view the full article, register now.
Already a subscriber? Click here to view full article